Rep. Gilbert Ray Cisneros, Jr. Buys Kenvue Inc. (NYSE:KVUE) Stock

Key Points

• Rep. Gilbert Ray Cisneros, Jr. disclosed on March 9 that he purchased between $1,001 and $15,000 of Kenvue Inc. (KVUE) shares on Feb. 10 through his "150 MAIN STREET TRUST > BANK OF AMERICA" account.
• Kenvue reported a quarterly beat (EPS $0.27 vs. $0.22 consensus) with revenue of $3.78B (up 3.2% y/y) and pays an annualized dividend of $0.83 (~4.7% yield), though its dividend payout ratio is about 107.8%.
• Company insider Director Jeffrey C. Smith bought 3.2 million KVUE shares for roughly $55.6 million in December, while analysts maintain an overall "Hold" consensus with an average price target near $19.58.

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of Kenvue Inc. (NYSE:KVUE). In a filing disclosed on March 09th, the Representative disclosed that they had bought between $1,001 and $15,000 in Kenvue stock on February 10th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Thermon Group NYSE: THR on 3/2/2026.
• Purchased $1,001 - $15,000 in shares of Federal Signal NYSE: FSS on 3/2/2026.
• Purchased $1,001 - $15,000 in shares of Taiwan Semiconductor Manufacturing NYSE: TSM on 2/26/2026.
• Sold $1,001 - $15,000 in shares of Uber Technologies NYSE: UBER on 2/24/2026.
• Sold $1,001 - $15,000 in shares of Robinhood Markets NASDAQ: HOOD on 2/24/2026.
• Purchased $1,001 - $15,000 in shares of Micron Technology NASDAQ: MU on 2/24/2026.
• Sold $1,001 - $15,000 in shares of Oracle NYSE: ORCL on 2/24/2026.
• Purchased $1,001 - $15,000 in shares of Champion Homes NYSE: SKY on 2/23/2026.
• Sold $1,001 - $15,000 in shares of Tri Pointe Homes NYSE: TPH on 2/23/2026.
• Sold $1,001 - $15,000 in shares of Xiaomi OTCMKTS: XIACF on 2/20/2026.

Kenvue Price Performance

KVUE stock opened at $17.68 on Thursday. The company has a quick ratio of 0.68, a current ratio of 0.96 and a debt-to-equity ratio of 0.66. The firm has a market cap of $33.88 billion, a price-to-earnings ratio of 22.95, a PEG ratio of 4.11 and a beta of 0.51. The company's fifty day simple moving average is $17.89 and its 200 day simple moving average is $17.35. Kenvue Inc. has a 12-month low of $14.02 and a 12-month high of $25.17.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share for the quarter, topping analysts' consensus estimates of $0.22 by $0.05. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The firm had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $3.68 billion. During the same period last year, the business posted $0.26 EPS. The business's revenue was up 3.2% compared to the same quarter last year. On average, analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th were paid a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a yield of 4.7%. The ex-dividend date of this dividend was Wednesday, February 11th. Kenvue's dividend payout ratio (DPR) is currently 107.79%.

Analysts Set New Price Targets

KVUE has been the topic of several research analyst reports. Barclays upped their target price on Kenvue from $18.00 to $19.00 and gave the company an "equal weight" rating in a research report on Friday, March 6th. Weiss Ratings reissued a "hold (c-)" rating on shares of Kenvue in a research note on Friday, January 9th. Citigroup increased their price target on Kenvue from $18.00 to $20.00 and gave the stock a "neutral" rating in a report on Wednesday, February 18th. Zacks Research upgraded shares of Kenvue from a "strong sell" rating to a "hold" rating in a research note on Wednesday, November 26th. Finally, Argus upgraded shares of Kenvue to a "hold" rating in a research report on Friday, March 6th. Three research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $19.58.

Insider Buying and Selling at Kenvue

In other Kenvue news, Director Jeffrey C. Smith acquired 3,200,000 shares of Kenvue stock in a transaction dated Friday, December 12th. The stock was purchased at an average cost of $17.37 per share, for a total transaction of $55,584,000.00. Following the completion of the acquisition, the director directly owned 27,307,632 shares of the company's stock, valued at $474,333,567.84. This represents a 13.27% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.68% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Norges Bank bought a new stake in shares of Kenvue during the fourth quarter valued at approximately $756,862,000. Independent Franchise Partners LLP grew its position in Kenvue by 233.4% in the 2nd quarter. Independent Franchise Partners LLP now owns 31,265,574 shares of the company's stock valued at $654,388,000 after purchasing an additional 21,886,537 shares during the period. Sculptor Capital LP grew its position in Kenvue by 1,023.5% in the 4th quarter. Sculptor Capital LP now owns 12,886,328 shares of the company's stock valued at $222,289,000 after purchasing an additional 11,739,328 shares during the period. Capitolis Liquid Global Markets LLC increased its stake in Kenvue by 1,116.8% during the 4th quarter. Capitolis Liquid Global Markets LLC now owns 10,950,999 shares of the company's stock valued at $188,905,000 after purchasing an additional 10,050,999 shares in the last quarter. Finally, Cibc World Markets Corp acquired a new position in Kenvue during the fourth quarter worth $162,193,000. 97.64% of the stock is owned by institutional investors and hedge funds.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election. Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.